Medical Ethics Advisor – October 1, 2003
October 1, 2003
View Issues
-
Too high a price? Re-examining the ethics of Phase I oncology trials
For cancer patients who have exhausted all available treatment options, Phase I research trials of new oncology drugs may be their only hope. But does that hope come at too high a price? -
Circumcision: Support or circumscription?
Would your ethics committee approve a request to perform nontherapeutic surgery that would permanently alter the body of a healthy patient without his or her consent? What if the patient was very young and the parents wanted the surgery for religious or cultural reasons? -
Privacy regs complicate communication for care
The privacy regulations enacted as part of the federal Health Insurance Portability and Accountability Act (HIPAA) have caused some unforeseen complications for hospitals trying to ensure patient safety and improve communication between providers and patients, say health care professionals and legal experts. -
News Briefs
Updated EMTALA rule eases hospitals risk; Johns Hopkins program loses its accreditation; AMA to provide ethics alerts to MDs -
Audio conference clarifies final EMTALA regulations